146 related articles for article (PubMed ID: 31626962)
1. Convection enhanced delivery of anti-angiogenic and cytotoxic agents in combination therapy against brain tumour.
Zhan W
Eur J Pharm Sci; 2020 Jan; 141():105094. PubMed ID: 31626962
[TBL] [Abstract][Full Text] [Related]
2. Convection enhanced delivery of chemotherapeutic drugs into brain tumour.
Zhan W; Wang CH
J Control Release; 2018 Feb; 271():74-87. PubMed ID: 29274437
[TBL] [Abstract][Full Text] [Related]
3. Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy.
Zhan W; Wang CH
J Control Release; 2018 Sep; 285():212-229. PubMed ID: 30009891
[TBL] [Abstract][Full Text] [Related]
4. Effect of tissue permeability and drug diffusion anisotropy on convection-enhanced delivery.
Zhan W; Rodriguez Y Baena F; Dini D
Drug Deliv; 2019 Dec; 26(1):773-781. PubMed ID: 31357890
[TBL] [Abstract][Full Text] [Related]
5. Mathematical Modelling of Convection Enhanced Delivery of Carmustine and Paclitaxel for Brain Tumour Therapy.
Zhan W; Arifin DY; Lee TK; Wang CH
Pharm Res; 2017 Apr; 34(4):860-873. PubMed ID: 28155074
[TBL] [Abstract][Full Text] [Related]
6. Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis.
Mollard S; Ciccolini J; Imbs DC; El Cheikh R; Barbolosi D; Benzekry S
Oncotarget; 2017 Apr; 8(14):23087-23098. PubMed ID: 28416742
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic drug transport to brain tumor.
Arifin DY; Lee KY; Wang CH
J Control Release; 2009 Aug; 137(3):203-10. PubMed ID: 19376172
[TBL] [Abstract][Full Text] [Related]
8. Role of Tissue Hydraulic Permeability in Convection-Enhanced Delivery of Nanoparticle-Encapsulated Chemotherapy Drugs to Brain Tumour.
Yang Y; Zhan W
Pharm Res; 2022 May; 39(5):877-892. PubMed ID: 35474156
[TBL] [Abstract][Full Text] [Related]
9. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transport of chemotherapeutic drugs in voxelized heterogeneous model of human brain tumor.
Bhandari A; Bansal A; Singh A; Gupta RK; Sinha N
Microvasc Res; 2019 Jul; 124():76-90. PubMed ID: 30923021
[TBL] [Abstract][Full Text] [Related]
11. Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.
Zhang R; Saito R; Mano Y; Kanamori M; Sonoda Y; Kumabe T; Tominaga T
J Neurosci Methods; 2014 Jan; 222():131-7. PubMed ID: 24269253
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys.
Xu L; Zuch CL; Lin YS; Modi NB; Lum BL
Cancer Chemother Pharmacol; 2008 Apr; 61(4):607-14. PubMed ID: 17549476
[TBL] [Abstract][Full Text] [Related]
13. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts.
Krauze MT; Noble CO; Kawaguchi T; Drummond D; Kirpotin DB; Yamashita Y; Kullberg E; Forsayeth J; Park JW; Bankiewicz KS
Neuro Oncol; 2007 Oct; 9(4):393-403. PubMed ID: 17652269
[TBL] [Abstract][Full Text] [Related]
14. Role of convective flow in carmustine delivery to a brain tumor.
Arifin DY; Lee KY; Wang CH; Smith KA
Pharm Res; 2009 Oct; 26(10):2289-302. PubMed ID: 19639394
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Contrast-enhanced Magnetic Resonance Imaging for Patients with Breast Cancer Receiving First-line Bevacizumab and Paclitaxel.
Nakatsukasa K; Ouchi Y; Sakaguchi K; Goto M; Konishi E; Taguchi T
Anticancer Res; 2018 Sep; 38(9):5459-5463. PubMed ID: 30194203
[TBL] [Abstract][Full Text] [Related]
16. Convection-Enhanced Delivery of Antiangiogenic Drugs and Liposomal Cytotoxic Drugs to Heterogeneous Brain Tumor for Combination Therapy.
Bhandari A; Jaiswal K; Singh A; Zhan W
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077714
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP).
Tu SM; Millikan RE; Pagliaro LC; Daliani D; Papandreou CN; Kim J; Chen DT; Williams DL; Logothetis CJ
Urol Oncol; 2003; 21(5):342-8. PubMed ID: 14670540
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response.
Cesca M; Morosi L; Berndt A; Fuso Nerini I; Frapolli R; Richter P; Decio A; Dirsch O; Micotti E; Giordano S; D'Incalci M; Davoli E; Zucchetti M; Giavazzi R
Mol Cancer Ther; 2016 Jan; 15(1):125-35. PubMed ID: 26494857
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
[TBL] [Abstract][Full Text] [Related]
20. Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor.
Yang X; Saito R; Nakamura T; Zhang R; Sonoda Y; Kumabe T; Forsayeth J; Bankiewicz K; Tominaga T
Drug Deliv; 2016; 23(3):781-6. PubMed ID: 24865286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
